Close
Almac
Achema middle east

Ingestible Dose By Singapore For Real-Time Radiation Track

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

AstraZeneca Commits $100mn for Pan-KRAS Inhibitor by Jacobio

AstraZeneca has gone ahead and committed $100 million to...

Laboratory Equipment Outsourcing Through CDMOs: Strategic and Cost Implications

Outsourcing laboratory infrastructure to CDMOs offers pharma companies critical agility, transforming fixed capital costs into flexible operational expenses while accessing cutting-edge technology like Cryo-EM.

Specialized Laboratory Equipment Requirements for Biologics and Biosimilar Development

The development of complex biological molecules requires a specialized toolkit distinct from traditional small-molecule chemistry. This article details the critical laboratory equipment—from advanced bioreactors to high-resolution characterization tools—that enables the precise engineering and rigorous analysis required for successful biologics and biosimilar innovation.
- Advertisement -

A novel discovery by the researchers at the National University of Singapore can go on to aid in the treatment of gastric cancer by improving the radiotherapy precision, which is mostly used in combination with treatment options ranging from surgery and chemotherapy to immunotherapy.

When it comes to the modern radiotherapy spectrum, the precision in terms of targeting human tissue while also making sure that the damage is minimised in the healthy tissue is crucial. That said, the low efficacy and variable outcomes happen to be a challenge because of patient diversity, varied delivery types, as well as treatment uncertainty.

In order to address these challenges, Professor Liu as well as his team have gone on to develop a novel ingestible X-ray dosimeter capsule that is capable of measuring the radiation dose as well as physiological changes in the pH and also temperature in real time during the stage of gastrointestinal radiotherapy.

As and when the capsule gets ingested and reaches the gastrointestinal tract, the nonscintillators will go on to exhibit a heightened luminescence in the increased X-ray radiation presence. A sensor that is within the capsule makes sure to measure the glow from the nanoscintillators so as to gauge the radiation that’s delivered to the area that’s being targeted.

Notably, the capsule dosimeter measures 7 mm in width and 18 mm in length, which happens to be a common size that is used across supplements as well as medicines and costs S$60 to get produced. Presently designed for monitoring the radiotherapy dose for gastric cancer, it can also be used to monitor treatment when it comes to varied malignancies with further personalization of the capsule size.

It is well to note that the research team is also working to bring their innovation more towards clinical application. Further research includes exacting the position of the capsule and its posture post ingestion, creating a seamless and robust system so as to anchor the capsule towards the intended site, and further computing the precision and accuracy of the ingestible dosimeter for a safe as well as an effective clinical usage.

Latest stories

Related stories

AstraZeneca Commits $100mn for Pan-KRAS Inhibitor by Jacobio

AstraZeneca has gone ahead and committed $100 million to...

Laboratory Equipment Outsourcing Through CDMOs: Strategic and Cost Implications

Outsourcing laboratory infrastructure to CDMOs offers pharma companies critical agility, transforming fixed capital costs into flexible operational expenses while accessing cutting-edge technology like Cryo-EM.

Specialized Laboratory Equipment Requirements for Biologics and Biosimilar Development

The development of complex biological molecules requires a specialized toolkit distinct from traditional small-molecule chemistry. This article details the critical laboratory equipment—from advanced bioreactors to high-resolution characterization tools—that enables the precise engineering and rigorous analysis required for successful biologics and biosimilar innovation.

Next-Generation Laboratory Equipment Redefining Drug Discovery Workflows

Advanced technologies such as AI-integrated high-throughput screening platforms and automated assay systems are fundamentally transforming early-stage pharmaceutical research. These innovations address critical bottlenecks in productivity and data quality, enabling research teams to accelerate timeline-to-candidate selection while enhancing the predictive accuracy of drug discovery campaigns.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »